S. Cramer
发表
F. Carlotti,
M. Rabelink,
W. Fibbe,
2014,
Experimental hematology.
P. Boulanger,
Saw-See Hong,
R. Hoeben,
2017,
Scientific Reports.
R. D. de Groot,
R. Hoeben,
S. Cramer,
2012,
PloS one.
A. Moor,
R. Hoeben,
S. Cramer,
1999,
Gene Therapy.
F. Carlotti,
E. Wiertz,
M. Gonçalves,
2012,
PloS one.
A. van der Eb,
E. Briët,
R. Hoeben,
1995,
Blood.
A. Houweling,
A. van der Eb,
O. Kranenburg,
1996,
Human gene therapy.
A. van der Eb,
E. Briët,
R. Hoeben,
1993,
Human gene therapy.
P. van de Putte,
A. van der Eb,
R. Hoeben,
2000,
Nucleic Acids Research.
A. van der Eb,
J. Alex,
E. Briët,
1996,
Molecular and cellular biology.
A. van der Eb,
A. Bout,
K. Hehir,
1998,
Human gene therapy.
R. Hoeben,
S. Cramer,
A. Zaldumbide,
2006
.
A. Eb,
E. Briët,
R. Hoeben,
1990
.
D. Modarelli,
S. Cramer,
C. Rajesh,
2001,
Organic letters.
S. Cramer,
J. Marinsky,
J. Ephraim,
1989,
Talanta.
L. V. van Putten,
S. Cramer,
P. Lelieveld,
1982,
European journal of cancer & clinical oncology.
L. V. van Putten,
T. Smink,
S. Cramer,
1979,
European journal of cancer.
W. V. van Weerden,
L. Mezzanotte,
T. Kirkland,
2020,
International journal of molecular sciences.
M. Magnusson,
M. Rabelink,
P. Boulanger,
2009,
The journal of gene medicine.
Jort Vellinga,
Diana J M van den Wollenberg,
Martijn J W E Rabelink,
2004,
Journal of Virology.
Y. Ariyurek,
M. Rabelink,
Taco G. Uil,
2010,
Nucleic acids research.
M. Lamfers,
M. Hornsveld,
G. van der Pluijm,
2021,
Human gene therapy.
P. Boulanger,
Saw-See Hong,
R. Hoeben,
2017,
Scientific Reports.
R. Hoeben,
S. Cramer,
V. Kemp,
2018,
Gene Therapy.
R. Offringa,
S. Cramer,
E. Schmidt,
1993,
Biochemical and biophysical research communications.
R. Hoeben,
S. Cramer,
V. Kemp,
2018,
Gene Therapy.
A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator
M. Rabelink,
J. Verhaagen,
S. Weening,
2010,
Biotechnology Letters.